SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales
11 references·1 citing·37 second hop
NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales (2003)NICE Methodological Guidelines and Decisi…Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)Opportunity costs and uncerta…On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales (2002)On being NICE in the UK: guid…Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones? (2002)Inclusion of drugs in provinc…Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? (2001)Wrong SIGN, NICE mess: is nat…Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. (1993)Guidelines for the adoption o…Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems (1993)Changing the problem to fit t…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Cost effectiveness/utility analyses (1992)Cost effectiveness/utility an…Health, Economics, and Health Economics (1983)Health, Economics, and Health…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…Critical ratios and efficient allocation (1973)Critical ratios and efficient…QALYs (2006)QALYsMeasurement of health state utilities for economic appraisal (1986)Methods for the economic evaluation of health care programmes (1987)Cost-effectiveness league tables: More harm than good? (1993)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial (2016)Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents (1989)QALYs and the equity-efficiency trade-off (1991)Assessing the costs of healthcare technologies in clinical trials. (1999)Cost effectiveness analysis in health care: contraindications (2002)Canʼt Get No Satisfaction? Will Pay for Performance Help? (2010)A methodological framework for assessing health indices (1985)Meta-Analyses of Randomized Controlled Trials (1987)A study of the quality of life and cost-utility of renal transplantation (1996)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)The problem of fair division (1948)The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature (2014)Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System (2017)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)Health Technology Assessment in Canada: 20 Years Strong? (2009)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life (1997)Net Health Benefits (1998)Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane (2001)Use of Quality Adjusted Life Years and Life Years Gained as Benchmarks in Economic Evaluations: A Critical Appraisal (2003)Information Created to Evade Reality (ICER) (2006)Cost-effectiveness ratios: in a league of their own (1994)Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results (2003)Healthcare Rationing by Proxy (2010)Dilemmas In Regulation Of The Market For Pharmaceuticals (2003)The Common Drug Review: A NICE start for Canada? (2005)Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path (2011)Utility approach to measuring health-related quality of life (1987)Recommendations for Reporting Cost-effectiveness Analyses (1996)Economics, health and health economics: HYEs versus QALYs (1993)QALYs and ethics: A health economist's perspective (1996)Advances in Health Economics (2002)
this work references cited by second hop

References

  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,118 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1973Critical ratios and efficient allocation280 cited
  • 1992Cost effectiveness/utility analyses277 cited
  • 1993Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.173 cited
  • 1983Health, Economics, and Health Economics123 cited
  • 2002Opportunity costs and uncertainty in the economic evaluation of health care interventions115 cited
  • 2001Wrong SIGN, NICE mess: is national guidance distorting allocation of resources?93 cited
  • 1993Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems87 cited
  • 2002Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?77 cited
  • 2002On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales72 cited

Cited by

  • 2006QALYs60 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work